Write a comment
New research on the International Space Station will include implantable drug delivery devices and an adhesive that can stimulate bone growth.
SpaceX will launch a resupply mission as early as Tuesday to deliver a payload of items developed by commercial companies that need to be tested in orbit. The launch window opens at 3:54 p.m. EST.
It will be the 26th commercial resupply se New research on the International Space Station will include implantable drug delivery devices and an adhesive that can stimulate bone growth.
SpaceX will launch a resupply mission as early as Tuesday to deliver a payload of items developed by commercial companies that need to be tested in orbit. The launch window opens at 3:54 p.m. EST.
It will be the 26th commercial resupply service mission by SpaceX and NASA. The Falcon 9 rocket is to be launched from the Kennedy Space Center in Florida.
The space-based research is sponsored by the ISS National Laboratory.
The bone-mending injectable adhesive, called Tetranite, was developed by medical device company RevBio. The adhesive is intended to speed bone growth after breaks and fractures. The research will focus on how Tetranite performs in microgravity.
The project to research an implantable drug-delivery device at the space station was announced in 2021 by the Houston Methodist Research Institute. The device is capable of being remotely activated to deliver a release of a drug inside the body on demand. The first delivery of research material was part of the 23rd resupply mission.
"If successful, the device could allow doctors to remotely control drug delivery in patients in remote areas of Earth, or even in astronauts during spaceflight," according to a news release.
In July, SpaceX's 25th resupply mission delivered material for an investigation into tissue chips, a device which mimics the function of natural human tissue.
The National Institute of Health collaborated with astronauts on research of tissue chips starting in 2019. Tissue chips mimick actual human tissue, allowing researchers to study and observe "molecular mechanisms" of a wide variety of diseases with the hope of discovering treatments.
Related Links
Space Tourism, Space Transport and Space Exploration News
|
| Tweet |
| Thanks for being there;
We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain. With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords. Our news coverage takes time and effort to publish 365 days a year. If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution. | ||
| SpaceDaily Monthly Supporter
$5+ Billed Monthly |  | SpaceDaily Contributor
$5 Billed Once credit card or paypal |
Calnetix Technologies' high-speed blower system delivered to ISS
Cerritos CA (SPX) Nov 11, 2022
Calnetix Technologies reports that NASA has completed ground testing of its new carbon dioxide (CO2) removal system and has successfully launched the high-speed blower system to the International Space Station (ISS). The CO2 removal system includes Calnetix's magnetically levitated in-line blower and a dual controller. "The completion of NASA's rigorous qualification testing is an important milestone and a validation of Calnetix's advanced magnetic technologies, and we look forward to its operatio ... read more